Gait Disturbances and Hips Bone Mineral Density

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by Tel-Aviv Sourasky Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier:
NCT01554605
First received: February 23, 2012
Last updated: March 14, 2012
Last verified: March 2012
  Purpose

The objective of this study is to investigate the role of gait disturbance as a cause for difference in Bone Mineral Density (BMD) between both hips. Each subject will undergo the following tests: Functional Mobility Testing, Gait analysis, Motion Analysis, Assessments for Balance and Gait and Cognitive assessments.


Condition
Difference in BMD Between Both Hips

Study Type: Observational
Study Design: Observational Model: Case-Crossover
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Tel-Aviv Sourasky Medical Center:

Estimated Enrollment: 40
Study Start Date: March 2012
  Eligibility

Ages Eligible for Study:   40 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

subjects will be recruited from the bone clinic

Criteria

Inclusion Criteria:

  1. differeneces in hips in Bone Mineral Density test in one group.
  2. Age 40-80.

Exclusion Criteria:

  1. bone disease,
  2. arthritis,
  3. congenital skeletal malformations,
  4. pregnancy,
  5. neurological disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier: NCT01554605     History of Changes
Other Study ID Numbers: TASMC-12-NV-648-CTIL
Study First Received: February 23, 2012
Last Updated: March 14, 2012
Health Authority: Israel: Ministry of Health

ClinicalTrials.gov processed this record on July 23, 2014